Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MCRB - Seres Therapeutics: The Pipeline Is The Problem

MCRB - Seres Therapeutics: The Pipeline Is The Problem

Seres Therapeutics Inc.
  • SER-109 has shown an excellent efficacy and safety profile but is entering a small and crowded market.
  • SER-287 and SER-301 have shown no efficacy.
  • SER-401 did not show efficacy in metastatic melanoma patients.
  • SER-155 has not yet achieved proof of concept but is the most promising asset in the pipeline.

For further details see:

Seres Therapeutics: The Pipeline Is The Problem
Stock Information
Company Name: Seres Therapeutics Inc.
Stock Symbol: MCRB
Market: NASDAQ
Website: serestherapeutics.com
Menu
MCRB MCRB Quote MCRB Short MCRB News MCRB Articles MCRB Message Board
Get MCRB Alerts

News, Short Squeeze, Breakout and More Instantly...